Garoufi A, Papadaki M, Kalogiannis M, Zerva U, Charakida M, Marmarinos A
Biomolecules. 2025; 14(12.
PMID: 39766315
PMC: 11674530.
DOI: 10.3390/biom14121608.
Spina A, Amone F, Zaccaria V, Insolia V, Perri A, Lofaro D
Foods. 2024; 13(23).
PMID: 39682955
PMC: 11641072.
DOI: 10.3390/foods13233883.
von Kanel-Cordoba I, Wirnitzer K, Weiss K, Nikolaidis P, Devrim-Lanpir A, Hill L
J Health Popul Nutr. 2024; 43(1):189.
PMID: 39563466
PMC: 11575005.
DOI: 10.1186/s41043-024-00679-0.
Xiao G, Gao S, Xie Y, Wang Z, Shu M
Medicina (Kaunas). 2024; 60(10).
PMID: 39459433
PMC: 11509226.
DOI: 10.3390/medicina60101646.
Chang C, Yeh C, Tiong C, Sun M, Lin J, Cherng Y
J Multidiscip Healthc. 2024; 17:3727-3738.
PMID: 39100903
PMC: 11297496.
DOI: 10.2147/JMDH.S466696.
Phytonutrients in the promotion of healthspan: a new perspective.
Jacquier E, Kassis A, Marcu D, Contractor N, Hong J, Hu C
Front Nutr. 2024; 11:1409339.
PMID: 39070259
PMC: 11272662.
DOI: 10.3389/fnut.2024.1409339.
Cholesterol-Lowering Bioactive Foods and Nutraceuticals in Pediatrics: Clinical Evidence of Efficacy and Safety.
Fogacci F, AlGhasab N, Di Micoli V, Giovannini M, Cicero A
Nutrients. 2024; 16(10).
PMID: 38794764
PMC: 11123713.
DOI: 10.3390/nu16101526.
Executive summary of the Hellenic Atherosclerosis Society guidelines for the diagnosis and treatment of dyslipidemias - 2023.
Katsiki N, Filippatos T, Vlachopoulos C, Panagiotakos D, Milionis H, Tselepis A
Atheroscler Plus. 2024; 55:74-92.
PMID: 38425675
PMC: 10901915.
DOI: 10.1016/j.athplu.2024.01.004.
Diet and Lipid-Lowering Nutraceuticals in Pediatric Patients with Familial Hypercholesterolemia.
Capra M, Biasucci G, Banderali G, Vania A, Pederiva C
Children (Basel). 2024; 11(2).
PMID: 38397362
PMC: 10887291.
DOI: 10.3390/children11020250.
An investigation of the effects of urolithins A and B on low-density lipoprotein uptake and its regulatory genes.
Ganjali S, Riahi M, Mahboobnia K, Iranshahy M, Banach M, Jangjoo A
Arch Med Sci. 2023; 19(6):1832-1841.
PMID: 38058736
PMC: 10696988.
DOI: 10.5114/aoms/168120.
Efficacy and underlying mechanisms of berberine against lipid metabolic diseases: a review.
Cai Y, Yang Q, Yu Y, Yang F, Bai R, Fan X
Front Pharmacol. 2023; 14:1283784.
PMID: 38034996
PMC: 10684937.
DOI: 10.3389/fphar.2023.1283784.
Characterization and Pharmacokinetic Assessment of a New Berberine Formulation with Enhanced Absorption In Vitro and in Human Volunteers.
Solnier J, Zhang Y, Kuo Y, Du M, Roh K, Gahler R
Pharmaceutics. 2023; 15(11).
PMID: 38004546
PMC: 10675484.
DOI: 10.3390/pharmaceutics15112567.
Metabolic and vascular effect of a new standardized bergamot phytocomplex: a three-arm, placebocontrolled, double-blind clinical trial.
Fogacci F, Giovannini M, Imbalzano E, Grandi E, Rizzoli E, DAddato S
Arch Med Sci. 2023; 19(5):1228-1235.
PMID: 37732063
PMC: 10507770.
DOI: 10.5114/aoms/163368.
Three arms, double-blind, non-inferiority, randomized clinical study testing the lipid-lowering effect of a novel dietary supplement containing red yeast rice and artichoke extracts compared to Armolipid Plus and placebo.
Cicero A, Fogacci F, Tocci G, DAddato S, Grandi E, Banach M
Arch Med Sci. 2023; 19(5):1169-1179.
PMID: 37732047
PMC: 10507752.
DOI: 10.5114/aoms/167969.
Comparative effect of a nutraceutical compound based on a flavonoid complex from bergamot on plasma lipids, glucose metabolism, and liver enzymes: a 3-arm, double-blind, placebo-controlled, randomized clinical trial.
Fogacci F, Di Micoli V, Veronesi M, Cicero A
Arch Med Sci. 2023; 19(5):1180-1185.
PMID: 37732027
PMC: 10507781.
DOI: 10.5114/aoms/152791.
Low Dose Monacolin K Combined with Coenzyme Q10, Grape Seed, and Olive Leaf Extracts Lowers LDL Cholesterol in Patients with Mild Dyslipidemia: A Multicenter, Randomized Controlled Trial.
Angelopoulos N, Paparodis R, Androulakis I, Boniakos A, Argyrakopoulou G, Livadas S
Nutrients. 2023; 15(12).
PMID: 37375586
PMC: 10303004.
DOI: 10.3390/nu15122682.
Red Yeast Rice for the Improvement of Lipid Profiles in Mild-to-Moderate Hypercholesterolemia: A Narrative Review.
Cicero A, Fogacci F, Pantea Stoian A, Toth P
Nutrients. 2023; 15(10).
PMID: 37242171
PMC: 10221652.
DOI: 10.3390/nu15102288.
Lipid-Lowering Nutraceuticals for an Integrative Approach to Dyslipidemia.
Cheung B, Sikand G, Dineen E, Malik S, Barseghian El-Farra A
J Clin Med. 2023; 12(10).
PMID: 37240523
PMC: 10219430.
DOI: 10.3390/jcm12103414.
Overall and Sex-Specific Effect of Berberine for the Treatment of Dyslipidemia in Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.
Blais J, Huang X, Zhao J
Drugs. 2023; 83(5):403-427.
PMID: 36941490
DOI: 10.1007/s40265-023-01841-4.
Could Lowering Phytosterol Absorption as Part of Lipid-Lowering Therapy Have a Beneficial Effect on Residual Risk?.
Anagnostis P, Kotsis V, Banach M, Mikhailidis D
Metabolites. 2023; 13(2).
PMID: 36837764
PMC: 9964413.
DOI: 10.3390/metabo13020145.